AI in Clinical and Molecular Diagnostics Market
商品番号 : SMB-67502
| 出版社 | BCC Research |
| 出版年月 | 2024年10月 |
| ページ数 | 112 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 5,500 |
| 種別 | 英文調査報告書 |
Report Highlights
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
臨床および分子診断における AI の世界市場は、2024 年の 26 億ドルから成長し、2029 年末までに 89 億ドルに達すると予測されています。2024 年から 2029 年の予測期間中に 27.6% の年平均成長率 (CAGR) が見込まれます。
Summary:
The global market for AI in clinical and molecular diagnostics was valued at $2.3 billion in 2023. It is expected to grow at a CAGR of 27.6% to reach $8.9 billion through 2029. The market is driven by the rising demand for accurate and efficient diagnostic solutions. Advances in AI technologies such as machine learning and deep learning are enhancing the capabilities of traditional diagnostic methods in areas like imaging, genomics and laboratory testing. Factors promoting market expansion include a growing emphasis on personalized medicine, the need for earlier disease detection and the integration of AI into healthcare systems. Major players in the market are investing in R&D, fostering strategic partnerships and expanding their product portfolios to leverage emerging opportunities. Countries in North America, Europe and Asia-Pacific are prioritizing digital health initiatives and innovative diagnostic solutions. The use of AI in clinical and molecular diagnostics will only grow, leading to breakthroughs that will improve patient outcomes and healthcare efficiency in the forecast period of 2024 to 2029.
Report Scope
This report on the global market for AI in clinical and molecular diagnostics entails a comprehensive analysis of the market size, growth trends and segmentation by technology and application. It examines drivers, challenges and opportunities influencing the adoption of AI technologies in clinical and molecular diagnostics, focusing on specific applications in imaging, genomics and laboratory diagnostics. The report provides perspectives on the competitive environment, featuring profiles of leading companies and their strategic initiatives, as well as regional analyses that address the specific market dynamics in North America, Europe, Asia-Pacific, and the Rest of the World (RoW), which in this report includes Latin America and the Middle East and Africa. It also identifies emerging trends, such as the integration of AI in personalized medicine and telehealth. This report is an essential reference for stakeholders, including healthcare providers, technology developers and policymakers, seeking to navigate and capitalize on the evolving AI landscape in diagnostics.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2023 | ||||||||||||||||||
| Forecast period considered | 2024-2029 | ||||||||||||||||||
| Base year market size | $2.3 billion | ||||||||||||||||||
| Market size forecast | $8.9 billion | ||||||||||||||||||
| Growth rate | CAGR of 27.6% for the forecast period of 2024-2029 | ||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||
| Segments covered | Type, Component, and Region | ||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World | ||||||||||||||||||
| Countries covered | U.S., Canada, Mexico, Germany, France, U.K., Italy, Russia, Spain, China, India, Japan, Australia, Singapore, South Korea, Latin America, Middle East and Africa | ||||||||||||||||||
| Key Market Drivers |
| ||||||||||||||||||
| Companies studied |
| ||||||||||||||||||
Report Includes
– 27 data tables and 41 additional tables
– An analysis of the current and future global markets for AI in clinical and molecular diagnostics
– Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
– Estimates of the market size and revenue forecasts for the global market for AI in clinical and molecular diagnostics, with market share analysis by type of services, devices, and region
– Discussion of the rising prevalence of chronic diseases, and technological advances in biomarker discovery, disease progression prediction, and personalized treatment strategies
– Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
– Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG scores, and consumer attitudes
– Competitive intelligence, including companies’ market shares, recent M&A activity and venture funding
– Profiles of the leading companies, including Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., Fujifilm Holdings Corp., and Merative
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
History of AI
Rise of Machine Learning
Machine Learning vs. Deep Learning vs. Neural Networks
Types of Machine Learning
Advantages and Disadvantages of ML Algorithms
AI in Healthcare
AI in Clinical Diagnostics
AI in Molecular Diagnostics
Chapter 3 Market Dynamics
Overview
Market Drivers
Investment in the AI Health Sector
Increasing Prevalence of Chronic and Infectious Diseases
Technological Advances
Demand for Personalized Medicine
Market Restraints
Practitioners Reluctant to Adopt AI-based Technologies
Data Security
Regulatory Challenges
Market Opportunities
Software with AI
Untapped Opportunities in Developing Markets
Chapter 4 Regulatory Structure
Chapter 5 Emerging Technologies and Developments
Latest Technologies/Developments
Machine Learning Algorithms
Deep Learning
Generative AI
Natural Language Processing (NLP)
Genomic AI
Cloud-Based Solutions
Chapter 6 Market Segmentation Analysis
Market Trends
Segmentation Breakdown
AI in Clinical and Molecular Diagnostics: Global Markets
Molecular Diagnostics
Clinical Diagnostics
Market Analysis by Component
Software
Services
Hardware
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Chapter 8 Sustainability in AI in Clinical and Molecular Diagnostics: An ESG Perspective
Environmental Sustainability
Positive Environmental Impacts
Negative Environmental Impacts
Social: Ensuring that AI Benefits All Society
Governance Impacts
Chapter 9 Appendix
Methodology
Sources
Abbreviations
Company Profiles
ATOMWISE INC.
- HOFFMANN-LA ROCHE LTD.
FUJIFILM HOLDINGS CORP.
GE HEALTHCARE
ILLUMINA INC.
KONINKLIJKE PHILIPS N.V.
MEDTRONIC
MICROSOFT CORP.
SIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC INC.
Vendors
BUTTERFLY NETWORK INC.
ENLITIC
INTEL CORP.
MERATIVE
NVIDIA CORP.
QURE.AI
SYNAPSICA HEALTHCARE PVT LTD.
List of Tables
Summary Table A : Global Market for AI in Clinical and Molecular Diagnostics, by Type, Through 2029
Summary Table B : Global Market for AI in Clinical and Molecular Diagnostics, by Region, Through 2029
Table 1 : Regulations Pertaining to AI Medical Diagnostics
Table 2 : Global Market for AI in Clinical and Molecular Diagnostics, Through 2029
Table 3 : Global Market for AI in Clinical and Molecular Diagnostics, by Type, Through 2029
Table 4 : Global Market for AI in Molecular Diagnostics, by Application, Through 2029
Table 5 : Incidence of Cancer, by Region, 2022
Table 6 : Number of DALYs for Neurological Disorders and Share of Global DALYs Projected for 2005 and 2030
Table 7 : Global Market for AI in Molecular Diagnostics, by Product Type, Through 2029
Table 8 : Global Market for AI in Clinical Diagnostics, by Test, Through 2029
Table 9 : Global Market for AI in Clinical Diagnostics, by Product, Through 2029
Table 10 : Global Market for AI in Clinical and Molecular Diagnostics, by Component, Through 2029
Table 11 : Global Market for AI in Clinical and Molecular Diagnostics, by Region, Through 2029
Table 12 : North American Market for AI in Clinical and Molecular Diagnostics, by Country, Through 2029
Table 13 : European Market for AI in Clinical and Molecular Diagnostics, by Country, Through 2029
Table 14 : Asia-Pacific Market for AI in Clinical and Molecular Diagnostics, by Country, Through 2029
Table 15 : RoW Market for AI in Clinical and Molecular Diagnostics, by Sub-Region, Through 2029
Table 16 : Recent Initiatives in the Market for AI in Clinical and Molecular Diagnostics, 2024
Table 17 : Report Sources
Table 18 : Abbreviations Used in this Report
Table 19 : Atomwise Inc.: Company Snapshot
Table 20 : Atomwise Inc.: Product Portfolio
Table 21 : Atomwise Inc: News/Key Developments, 2022
Table 22 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 23 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 24 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 25 : Fujifilm Holdings Corp.: Company Snapshot
Table 26 : Fujifilm Holdings Corp.: Financial Performance, FY 2022 and 2023
Table 27 : Fujifilm Holdings Corp.: Product Portfolio
Table 28 : GE HealthCare: Company Snapshot
Table 29 : GE HealthCare: Financial Performance, FY 2022 and 2023
Table 30 : GE HealthCare: Product Portfolio
Table 31 : Illumina: Company Snapshot
Table 32 : Illumina: Financial Performance, FY 2022 and 2023
Table 33 : Illumina: Product Portfolio
Table 34 : Koninklijke Philips N.V.: Company Snapshot
Table 35 : Koninklijke Philips N.V.: Financial Performance, FY 2022 and 2023
Table 36 : Koninklijke Philips N.V.: Product Portfolio
Table 37 : Medtronic: Company Snapshot
Table 38 : Medtronic: Financial Performance, FY 2022 and 2023
Table 39 : Medtronic: Product Portfolio
Table 40 : Microsoft Corp.: Company Snapshot
Table 41 : Microsoft Corp.: Financial Performance, FY 2022 and 2023
Table 42 : Microsoft Corp.: Product Portfolio
Table 43 : Microsoft Corp.: News/Key Developments, 2024
Table 44 : Siemens Healthineers AG: Company Snapshot
Table 45 : Siemens Healthineers AG: Financial Performance, FY 2022 and 2023
Table 46 : Siemens Healthineers AG: Product Portfolio
Table 47 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 48 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 49 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 50 : Butterfly Network Inc.: Company Snapshot
Table 51 : Butterfly Network Inc.: Financial Performance, FY 2022 and 2023
Table 52 : Butterfly Network Inc.: Product Portfolio
Table 53 : Enlitic: Company Snapshot
Table 54 : Enlitic: Product Portfolio
Table 55 : Intel Corp.: Company Snapshot
Table 56 : Intel Corp.: Financial Performance, FY 2022 and 2023
Table 57 : Intel Corp.: Product Portfolio
Table 58 : Merative: Company Snapshot
Table 59 : Merative: Product Portfolio
Table 60 : NVIDIA Corp.: Company Snapshot
Table 61 : NVIDIA Corp.: Financial Performance, FY 2022 and 2023
Table 62 : NVIDIA Corp.: Product Portfolio
Table 63 : Qure.ai: Company Snapshot
Table 64 : Qure.ai: Product Portfolio
Table 65 : Synapsica Healthcare Pvt Ltd.: Company Snapshot
Table 66 : Synapsica Healthcare Pvt Ltd.: Product Portfolio
List of Figures
Summary Figure A : Global Market for AI in Clinical and Molecular Diagnostics, by Type, 2021-2029
Summary Figure B : Global Market for AI in Clinical and Molecular Diagnostics, by Region, 2021-2029
Figure 1 : Market Dynamics of AI in Clinical and Molecular Diagnostics
Figure 2 : Global Market Shares of AI in Clinical and Molecular Diagnostics, by Type, 2023
Figure 3 : Global Market Shares of AI in Molecular Diagnostics, by Application, 2023
Figure 4 : Global Deaths from Cancer, 2015 and 2030
Figure 5 : Global Market Shares of AI in Molecular Diagnostics, by Product Type, 2023
Figure 6 : Global Market Shares of AI in Clinical Diagnostics, by Test, 2023
Figure 7 : Global Market Shares of AI in Clinical Diagnostics, by Product, 2023
Figure 8 : Global Market Shares of AI in Clinical and Molecular Diagnostics, by Component, 2023
Figure 9 : Global Market Shares of AI in Clinical and Molecular Diagnostics, by Region, 2023
Figure 10 : North American Market Shares of AI in Clinical and Molecular Diagnostics, by Country, 2023
Figure 11 : European Market Shares of AI in Clinical and Molecular Diagnostics, by Country, 2023
Figure 12 : Asia-Pacific Market Shares of AI in Clinical and Molecular Diagnostics, by Country, 2023
Figure 13 : RoW Market Shares of AI in Clinical and Molecular Diagnostics, by Sub-Region, 2023
Figure 14 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 15 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 16 : Fujifilm Holdings Corp.: Revenue Share, by Business Unit, FY 2023
Figure 17 : Fujifilm Holdings Corp.: Revenue Share, by Country/Region, FY 2023
Figure 18 : GE HealthCare: Revenue Share, by Business Unit, FY 2023
Figure 19 : GE HealthCare: Revenue Share, by Country/Region, FY 2023
Figure 20 : Illumina: Revenue Share, by Business Unit, FY 2023
Figure 21 : Illumina: Revenue Share, by Country/Region, FY 2023
Figure 22 : Koninklijke Philips N.V.: Revenue Share, by Business Unit, FY 2023
Figure 23 : Koninklijke Philips N.V.: Revenue Share, by Country/Region, FY 2023
Figure 24 : Medtronic: Revenue Share, by Business Unit, FY 2023
Figure 25 : Medtronic: Revenue Share, by Country/Region, FY 2023
Figure 26 : Microsoft Corp.: Revenue Share, by Business Unit, FY 2023
Figure 27 : Microsoft Corp.: Revenue Share, by Country/Region, FY 2023
Figure 28 : Siemens Healthineers AG: Revenue Share, by Business Unit, FY 2023
Figure 29 : Siemens Healthineers AG: Revenue Share, by Country/Region, FY 2023
Figure 30 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 31 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
Figure 32 : Butterfly Network Inc.: Revenue Share, by Business Unit, FY 2023
Figure 33 : Butterfly Network Inc.: Revenue Share, by Country/Region, FY 2023
Figure 34 : Intel Corp.: Revenue Share, by Business Unit, FY 2023
Figure 35 : Intel Corp.: Revenue Share, by Country/Region, FY 2023
Figure 36 : NVIDIA Corp.: Revenue Share, by Business Unit, FY 2023
Figure 37 : NVIDIA Corp.: Revenue Share, by Country/Region, FY 2023
BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。
ライセンス別価格表
2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
新価格表
ライセンスタイプ1
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 4,650 | USD 5,580 | USD 6,696 | USD 8,035 |
ライセンスタイプ2
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 2,950 | USD 3,540 | USD 4,248 | USD 5,098 |
ライセンスタイプ3
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 2,500 | USD 3,000 | USD 3,600 | USD 4,320 |
旧価格表
旧ライセンスタイプ1
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 5,500 | USD 6,600 | USD7.920 | USD 9,504 |
旧ライセンスタイプ2
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 3,500 | USD 4,200 | USD 5,040 | USD 6,048 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- 2-5ライセンス
- 同一企業内5名までレポートファイルのご利用が可能です。
- サイトライセンス
- 同一企業同住所内でレポートファイルのご利用が可能です。
- エンタープライズライセンス
- 同一企業内人数無制限でレポートファイルのご利用が可能です。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- ご注文後3営業日以内
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 食品小売業およびEコマースにおけるAIの世界市場 2025-11-14
- 免疫療法薬の世界市場 2025-11-12
- 農業におけるAIの世界市場 2025-11-10
- 固体酸化物形燃料電池の技術と世界市場 2025-11-07
- 世界の電気アーク炉市場 2025-11-07
